Upcoming Laboratorio Reig Jofre dividend
Change(%)
-51.02%
Decrease
Next payment 0.024€
Next payment date Jun 8, 2026
Last payment 0.049€
Last payment date Jun 2, 2025
00 D 00 H 00 M 00 S
Ex-Dividend: 5/21/26
Confirmed

Laboratorio Reig Jofre has scheduled the disbursement of its dividend of 0,024 euros per share, yielding 0.89%, for June 8, 2026.

The May 21, 2026 is the ex-dividend date. So if you wish to receive Laboratorio Reig Jofre dividends, you must buy one day before this date.

The dividend issued by Laboratorio Reig Jofre on June 2, 2025 amounted to 0.049 euros.

Reig Jofre rewards its associates according to the conditions approved by the General Shareholders' Meeting, offering two possibilities, one of which is the flexible dividend or "scrip dividend", which allows investors the possibility of receiving bonus shares in the company.

Another option is to receive the interest payment in cash, which is made annually in a single installment, at a fixed price, usually between the months of May and September, with a dividend yield of 1.60% and a payout of approximately 38%.

Payout Ratio Laboratorio Reig Jofre Dividends

Laboratorio Reig Jofre paid 9% of its net income in the last fiscal period as dividends.
Laboratorio Reig Jofre's earnings (335,008,000.00€) are sufficient to cover the dividend payment. This payment represents 9% of the total net profit of RJF.
Dividend payout ratio
Payout Ratio

Dividend calendar of Laboratorio Reig Jofre

These are the most important events of the Laboratorio Reig Jofre calendar in 2026:

Event Day
Last trading date May 20, 2026
Ex-Dividend (Ex-Date) May 21, 2026
Record date May 22, 2026
Date of payment June 8, 2026
Data confirmed by the company Laboratorio Reig Jofre (RJF).
Confirmed
Source
Historical annual dividend yields of Laboratorio Reig Jofre
Over the past 5 years, Laboratorio Reig Jofre has not consistently increased the annual dividend amount.
Increasing Dividends
Dividend yield
Dividend yield of Laboratorio Reig Jofre vs. the sector
Laboratorio Reig Jofre's dividend yield (0.90%) is below the sector average (1.45%).
Comparison with industry average
Laboratorio Reig Jofre's dividend yield is below the top 75% (1.45%) of the sector.
Evaluation with respect to competence.
Dividend yield history in Laboratorio Reig Jofre
Over the past 5 years, Laboratorio Reig Jofre's annual dividend income has fallen by more than 10%.
Dividend stability

Dividend history of Laboratorio Reig Jofre

In this table you can see the complete history:

YearEx-DividendAmountTotal
2026
05/21/2026
0.024 €
0.024 €
2025
05/15/2025
0.049 €
0.049 €
2024
05/17/2024
0.04 €
0.04 €
2023
05/05/2023
0.04 €
0.04 €
2022
06/15/2022
0.04 €
0.04 €
2021
06/10/2021
0.045 €
0.045 €
2020
09/16/2020
0.039 €
0.039 €
2019
05/07/2019
0.045 €
0.045 €
2018
06/15/2018
0.046 €
0.046 €
2013
06/06/2013
0.74 €
0.74 €
Laboratorio Reig Jofre dividend capture strategy
Step 1: Buy Laboratorio Reig Jofre shares (RJF) one day before ex-dividend date
Date of purchase May 20, 2026
Next ex-dividend date May 21, 2026
Step 2: Sell Laboratorio Reig Jofre shares (RJF) when the price recovers.
Date of sale (estimated) May 21, 2026
Average price recovery 0 days
Average return on cost N/A
The dividend capture strategy is based on historical Laboratorio Reig Jofre data. Past performance is no guarantee of future results.

Information about Laboratorio Reig Jofre

Full name Laboratorio Reig Jofre, S.A.
Ticker RJF
Sector Health Care
Industry Drug Manufacturers - Specialty & Generic
Market Capitalization 222.43 €
Number of Employees 1,400
Description of the company

Reig Jofre, is a company dedicated to the pharmaceutical industry specialized in the research, development, manufacture and marketing of medicines and food supplements.

It was founded in 1929 in Barcelona and currently has four production and development centers in Europe, although its products are available in more than 70 countries, with its own subsidiaries in 8 of them, France, Portugal, Belgium, United Kingdom, Poland, Sweden, Singapore and Spain, supported by more than 130 commercial partners.

Its activity is structured in three business units, "Pharmaceutical Technologies", a unit dedicated to injectable drugs and antibiotics, "Specialty Pharmacare", specialized in dermatology, women's health and osteoarticular health, and "Consumer Healthcare", dedicated to the manufacture of food supplements, topical disinfectants and alcohols.

Frequently asked questions about Laboratorio Reig Jofre dividends

Laboratorio Reig Jofre pays dividends on a Anual basis.

Laboratorio Reig Jofre is listed on the and is part of the Ibex Small.

Laboratorio Reig Jofre has the Ticker or stock code RJF.

The CEO of Laboratorio Reig Jofre in 2026 is Mr. Ignasi Biosca Reig.

Laboratorio Reig Jofre does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.

Laboratorio Reig Jofre ForumCheck the latest comments and participate in the live chat on Laboratorio Reig Jofre stocks (RJF).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments